ONCOPRO NCCN LUNG CANCER PANEL WITH PD-L1 Test
Test Name: ONCOPRO NCCN LUNG CANCER PANEL WITH PD-L1 Test
Components: *EGFR *ALK *ERBB2 *BRAF *MET *RET *ROS1 *NTRK1 *KRAS*MSI *PD-L1
Price: 28080.0 AED
Sample Condition: 20 mL whole blood in 2 Streck tubes available from LPL AND 8 mL whole blood in 1 Lavender Top (EDTA) tube. Add the preservative supplied in the collection kit to the EDTA tube using a syringe & needle. Ship immediately at 18-22°C. DO NOT REFRIGERATE OR FREEZE. Duly filled OncoPro Liquid Biopsy Clinical Information Form (Form 32) is mandatory.
Report Delivery: 35 Working days
Method: Next Generation Sequencing, Extraction, Staining
Test type: Cancer
Doctor: Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information: Duly filled OncoPro Liquid Biopsy Clinical Information Form (Form 32) is mandatory.
Test Details
The Oncopro NCCN Lung Cancer Panel with PD-L1 Test is a diagnostic test used to detect lung cancer and assess the expression of PD-L1, a protein that can help predict the response to certain immunotherapy treatments. The test analyzes genetic mutations and other biomarkers in the tumor tissue to determine the best treatment options for the patient.
It is based on the National Comprehensive Cancer Network (NCCN) guidelines, which are widely accepted as the standard of care for cancer treatment. The PD-L1 test measures the amount of PD-L1 protein present on the surface of tumor cells. This information can help determine if the patient is a candidate for certain immunotherapy drugs that target the PD-L1 pathway.
Overall, the Oncopro NCCN Lung Cancer Panel with PD-L1 Test is a valuable tool for physicians in making treatment decisions for patients with lung cancer.
Test Name | ONCOPRO NCCN LUNG CANCER PANEL WITH PD-L1 Test |
---|---|
Components | *EGFR *ALK *ERBB2 *BRAF *MET *RET *ROS1 *NTRK1 *KRAS*MSI *PD-L1 |
Price | 28080.0 AED |
Sample Condition | 20 mLwhole bloodin 2 Streck tubes available from LPL AND8 mL whole bloodin 1 Lavender Top (EDTA) tube. Add the preservative supplied in the collection kit to the EDTA tube using a syringe & needle. Ship immediately at 18\u0192??22?\u00f8C. DO NOT REFRIGERATE OR FREEZE. Duly filled OncoPro Liquid Biopsy Clinical Information Form (Form 32)is mandatory. |
Report Delivery | 35 Working days |
Method | Next Generation Sequencing, Extraction, Staining |
Test type | Cancer |
Doctor | Oncologist |
Test Department: | MOLECULAR DIAGNOSTICS |
Pre Test Information | Duly filled OncoPro Liquid Biopsy Clinical Information Form (Form 32)is mandatory. |
Test Details | The Oncopro NCCN Lung Cancer Panel with PD-L1 Test is a diagnostic test used to detect lung cancer and assess the expression of PD-L1, a protein that can help predict the response to certain immunotherapy treatments. The test analyzes genetic mutations and other biomarkers in the tumor tissue to determine the best treatment options for the patient. It is based on the National Comprehensive Cancer Network (NCCN) guidelines, which are widely accepted as the standard of care for cancer treatment. The PD-L1 test measures the amount of PD-L1 protein present on the surface of tumor cells. This information can help determine if the patient is a candidate for certain immunotherapy drugs that target the PD-L1 pathway. Overall, the Oncopro NCCN Lung Cancer Panel with PD-L1 Test is a valuable tool for physicians in making treatment decisions for patients with lung cancer. |